Steven Perrin

Steven Perrin

Förmögenhet: 3 810 $ per 2026-05-31

61 år
Health Technology
Consumer Services
Commercial Services

Profil

Steven N.
Perrin
is the founder of Anelixis Therapeutics, Inc., founded in 2013, where the titles held included President, CEO, Treasurer & Director.
Current jobs include Executive Chairman at ALS Therapy Development Foundation, Inc. since 2018 (job started in 2007) and President, Chief Scientific Officer & Director at Eledon Pharmaceuticals, Inc. since 2020.
Former jobs include Associate Director-Molecular Profiling at Biogen, Inc. from 2001 to 2006, Scientist at Biogen MA, Inc., ARIAD Pharmaceuticals, Inc., and Aventis Pharmaceuticals, Inc., Assistant Professor at Boston University, Principal at Hoechst Ariad Genomics Center Llc, and Associate Professor at Boston University School of Medicine.
Education includes an undergraduate degree from Boston College in 1987 and a doctorate from Boston University School of Medicine in 1994.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-03-31 1 000 ( 0 % ) 3 810 $ 2026-05-31

Aktiva positioner av Steven Perrin

FöretagPositionStart
ELEDON PHARMACEUTICALS, INC. President 2020-09-14
Ordförande 2010-06-01

Tidigare kända positioner av Steven Perrin

FöretagPositionSlut
BIOGEN INC. Företagsledare/Principal 2006-12-01
Företagsledare/Principal -
Grundare -
Företagsledare/Principal -
Företagsledare/Principal -
Se detaljerna i Steven Perrins erfarenhet

Steven Perrins utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

86

Första gradens relationer

11

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag11

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Steven Perrin